Vaccines for seasonal flu are in short supply because production has dropped amid high demand for the H1N1 swine flu vaccine, the Health, Labor and Welfare Ministry said Saturday.
Domestic drug makers are expected to supply enough vaccine for the seasonal flu to treat about 45.04 million adults, or 80 percent of last year’s total, the ministry said.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.